Feedback / Questions
AB821 - Asher Biotherap
AB248 - Asher Biotherap
https://www.businesswire.com/news/home/20221005005167/en/Asher-Bio-to-Present-New-Preclinical-Data-for-CD8-T-Cell-Targeted-Immunotherapies-AB248-and-AB821-at-SITC%C2%A02022
Oct 5, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next